Author name: Prashant Reddy

T. Prashant Reddy graduated from the National Law School of India University, Bangalore, with a B.A.LLB (Hons.) degree in 2008. He later graduated with a LLM degree (Law, Science & Technology) from the Stanford Law School in 2013. Prashant has worked with law firms in Delhi and in academia in India and Singapore. He is also co-author of the book Create, Copy, Disrupt: India's Intellectual Property Dilemmas (OUP).

SpicyIP Tidbit: Copyright (Amendment) Bill, 2010 listed for debate & voting today

/ By / Copyright

The Copyright (Amendment) Bill, 2010 has been listed as Item No. 3 on today’s ‘list of business‘ for the Rajya Sabha and will be taken up for a debate and voting once the Rajya Sabha concludes its debate on the budget i.e. Finance Bill, 2012 along with a bill for appropriation of funds. Also on the list before the Copyright (Amendment) Bill, 2010 is a move to amend the rules pertaining to development fees for airports.  For those of you […]

SpicyIP Tidbit: Copyright (Amendment) Bill, 2010 listed for debate & voting today Read More »

Kardam singlehandedly kills transparency at the IPO; sends it back to the dark ages

/ By / Uncategorized

In a telephonic conversation with Sumathi earlier this evening, Dr. Kardam informed her that he had no intention of reviewing his earlier order rejecting her appeal against the order of the Central Public Information Officer (CPIO) at the G.I. Registry, who had priced the information which we had requested for at Rs. 10 per page. Given that Dr. Kardam is not going to review his patently wrong order, it now follows that no information pertaining to patent, trademark and G.I.

Kardam singlehandedly kills transparency at the IPO; sends it back to the dark ages Read More »

Customs Board issues circular allowing ‘parallel imports’ under Patents Act and Trademarks Act

/ By / Patent, Trademark

In a circular dated 8th May, 2012 (available over here) the Central Board of Customs & Excise (CBEC) has instructed all of its officers that the IPR (Imported Goods) Enforcement Rules, 2007 will not apply to ‘parallel imports’ under the Patents Act, 1970 and the Trademarks Act, 1999. The circular states that this interpretation of the law is based on the views of the DIPP, which is the nodal government agency for the implementation of the patents and trademarks legislation.

Customs Board issues circular allowing ‘parallel imports’ under Patents Act and Trademarks Act Read More »

Yet another baffling judgment from the Delhi High Court extinguishes the rights of composers & lyricists

/ By / Copyright

In yet another setback to composers and lyricists of music in India, a Division Bench of the Delhi High Court in the case of IPRS v. Aditya Pandey & CRI Events, has dismissed IPRS’s appeal against the order of a Single Judge who had held that radio stations etc., who were broadcasting/communicating ‘sound recordings’ were required to pay royalty to only the owner of the sound recording and not the owner of the lyrics or the musical works which had

Yet another baffling judgment from the Delhi High Court extinguishes the rights of composers & lyricists Read More »

Parliamentary Standing Committee on Health tables damning report on the dangerous liaisons between the DCGI & the pharmaceutical industry

/ By / Drug Regulation

In what is probably a first of its kind report in independent India, the Parliamentary Standing Committee on Health & Family Welfare has tabled before Parliament a unanimous, damning report on the state of drug regulation in India and the manner in which it severely compromises the safety of Indian patients. The 118 pages report which is exhaustive, thoroughly researched and cross-referenced, and at times forensic in its examination of the evidence before it, raises very serious issues of subversion

Parliamentary Standing Committee on Health tables damning report on the dangerous liaisons between the DCGI & the pharmaceutical industry Read More »

CSIR agrees to disclose royalties from its patent licencing activities for a period of 10 years

/ By / Uncategorized

In a welcome decision, Joint Secretary Dr. Jayakumar (IAS), who is the Appellate Authority for the implementation of the RTI Act, 2005 at the Council for Scientific & Industrial Research (CSIR) has agreed to disclose all royalties earned by CSIR through its patent licensing agreements for a period of the last 10 years. Image from here. The CPIO at CSIR HQs had earlier turned down my request to provide this information on the grounds that it was ‘confidential’ and also

CSIR agrees to disclose royalties from its patent licencing activities for a period of 10 years Read More »

Supreme Court rules against interim CLs by the Copyright Board

/ By / Copyright

In a decision dated 3rd May, 2012, a bench of three judges of the Supreme Court overruled a Division Bench order of the Delhi High Court which had held that the Copyright Board had the power to grant interim compulsory licences under Section 31. The order of the Supreme Court can be accessed over here on the Indian Kanoon website and Mathew’s post on the earlier order of the Delhi High Court can be accessed over here. Radio stations have

Supreme Court rules against interim CLs by the Copyright Board Read More »

IPAB dismisses patent revocation petition for lack of evidence

/ By / Uncategorized

Image from here In a decision dated the 9th of March, 2012, the Intellectual Property Appellate Board (IPAB), dismissed a revocation petition under Section 64 of the Patents Act, 1970. The petition had been filed by The Travancore Mats & Matting Co. against patent no: 206494 which had been granted by the Patent Office for an invention titled “A method of making coir tufted rubber mats”.  The reason for dismissing the revocation petition was the failure of the petitioner to

IPAB dismisses patent revocation petition for lack of evidence Read More »

Tracking the inventors of Ranbaxy’s new anti-malarial drug

/ By / Innovation

A photograph of a few of the inventors, sourced from the MMV website. As discussed by Akshat in his guest post over here, the main invention in Ranbaxy’s new combination anti-malarial drug is the new chemical entity (NCE) by the name arterolane. While reading the several news reports on Ranbaxy’s new FDC anti-malarial drug, Synriam, I was quite surprised that nobody in the Indian press even bothered to mention the names of the inventors. This is in sharp contrast to

Tracking the inventors of Ranbaxy’s new anti-malarial drug Read More »

USTR 301 Report surprisingly restrained on Bayer CL decision

/ By / Uncategorized

The Annual 301 Report by the United State Trade Representative (USTR) has recently been published by the Office of the USTR and can be accessed over here. Predictably, the USTR has once again put India on its ‘priority watch-list’ for poor compliance with the standards of intellectual property law expected by the U.S. The USTR 301 reports are usually quite aggressive in demanding higher standard of IP protections from all countries regardless of the domestic priorities of these individual countries.

USTR 301 Report surprisingly restrained on Bayer CL decision Read More »

Scroll to Top